** Shares of clinical research service provider Syneos
Health Inc SYNH.O up 12.8% at $43.3 before the bell
** A consortium is nearing a deal to buy Syneos for about
$43/share in cash, Reuters reports
** The consortium of Elliott Investment Management, Patient
Square Capital and Veritas Capital is looking to buy SYNH for
more than $7 bln, including debt
** The per-share price is 14% higher than the stock's value
on Feb. 24, the last trading day before Reuters reported Syneos
was exploring a sale
** Since then, the stock has traded in a range of $43.35 to
$32.74; analysts median PT is $40, per Refinitiv data
(Reporting by Khushi Mandowara in Bengaluru)
((Khushi.Mandowara@thomsonreuters.com;))